JANUX THERAPEUTICS INC's ticker is JANX and the CUSIP is 47103J105. A total of 55 filers reported holding JANUX THERAPEUTICS INC in Q2 2023. The put-call ratio across all filers is 0.08 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $16,526,956 | +16.6% | 1,639,579 | +37.3% | 0.00% | – |
| Q2 2023 | $14,179,758 | +3.3% | 1,194,588 | +5.3% | 0.00% | – |
| Q1 2023 | $13,729,205 | -5.5% | 1,134,645 | +2.9% | 0.00% | – |
| Q4 2022 | $14,527,234 | -14.2% | 1,103,055 | -11.8% | 0.00% | -100.0% |
| Q3 2022 | $16,929,000 | +14.7% | 1,250,348 | +3.5% | 0.00% | – |
| Q2 2022 | $14,754,000 | -11.4% | 1,208,354 | +4.0% | 0.00% | – |
| Q1 2022 | $16,659,000 | -16.3% | 1,161,721 | +15.2% | 0.00% | -100.0% |
| Q4 2021 | $19,892,000 | +14.7% | 1,008,261 | +25.8% | 0.00% | – |
| Q3 2021 | $17,341,000 | +532.2% | 801,778 | +629.2% | 0.00% | – |
| Q2 2021 | $2,743,000 | – | 109,947 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RA Capital Management | 8,670,644 | $104,914,792 | 2.38% |
| EcoR1 Capital, LLC | 3,838,486 | $46,445,681 | 1.50% |
| Samsara BioCapital, LLC | 360,414 | $4,361,009 | 0.90% |
| BVF INC/IL | 1,585,677 | $19,186,692 | 0.70% |
| Orbimed Advisors | 2,836,386 | $34,320,271 | 0.67% |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 900,000 | $10,890,000 | 0.02% |
| Woodline Partners LP | 137,300 | $1,661,330 | 0.02% |
| Vident Investment Advisory, LLC | 55,483 | $671,344 | 0.02% |
| JANUS HENDERSON GROUP PLC | 1,869,076 | $22,611,527 | 0.02% |
| FMR LLC | 10,281,288 | $124,403,584 | 0.01% |